Lucence Diagnostics Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes Premium Researchers used the amplicon-based LiquidHallmark test to correlate tumor DNA changes with treatment response. Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance Premium The firm shared validation data at ASCO on its LiquidHallmark assay to help guide detection and treatment decisions for late-stage cancers. Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer The study will recruit 200 non-small cell lung cancer patients, comparing results of the company's ctDNA testing to tissue next-generation sequencing. Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform The partners believe the platform, which captures high resolution images of CTCs and clusters, has potential applications in early cancer detection and disease monitoring. Lucence Obtains CLIA Certification for Palo Alto Lab The firm will scale US-based testing capacity for its LiquidHallmark liquid biopsy assay, which uses amplicon-based technology to detect cancer-related mutations. May 29, 2020 Lucence Dx Liquid Biopsy Tech Detects Structural Rearrangements, Breast Cancer Mutations Premium Jan 27, 2020 Lucence Dx Targets Late-Stage Lung Cancer Monitoring With 2020 US Entry Premium Nov 19, 2019 Cancer Diagnostics Firm Lucence Raises $20M Nov 7, 2019 Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China Mar 12, 2019 Lucence Dx, Stanford University Applying AI to Liver Cancer Diagnosis, Treatment Nov 26, 2018 Lucence Dx Inks India Distribution Deal for Liquid Biopsy Test Oct 26, 2018 New Products Posted to GenomeWeb: MGI, Lucence Diagnostics, SeraCare, More Sep 18, 2018 Lucence Diagnostics Names Myanmar Distribution Partner for Cancer Dx Tests Aug 13, 2018 Lucence Dx Signs Philippine Distribution Deal for Cancer Tests Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.